<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37261347</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases.</ArticleTitle><Pagination><StartPage>1166536</StartPage><MedlinePgn>1166536</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1166536</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1166536</ELocationID><Abstract><AbstractText>Epigenetic modification is a complex process of reversible and heritable alterations in gene function, and the combination of epigenetic and metabolic alterations is recognized as an important causative factor in diseases such as inflammatory bowel disease (IBD), osteoarthritis (OA), systemic lupus erythematosus (SLE), and even tumors. Mesenchymal stem cell (MSC) and MSC-derived exosome (MSC-EXO) are widely studied in the treatment of inflammatory diseases, where they appear to be promising therapeutic agents, partly through the potent regulation of epigenetic modifications such as DNA methylation, acetylation, phosphorylation, and expression of regulatory non-coding RNAs, which affects the occurrence and development of inflammatory diseases. In this review, we summarize the current research on the role of MSC-EXO in inflammatory diseases through their modulation of epigenetic modifications and discuss its potential application in the treatment of inflammatory diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zhao, Zhang, Ocansey, Wang and Mao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zihan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocansey</LastName><ForeName>Dickson Kofi Wiredu</ForeName><Initials>DKW</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Directorate of University Health Services, University of Cape Coast, Cape Coast, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epigenetic modification</Keyword><Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">mesenchymal stem cell-derived exosome</Keyword><Keyword MajorTopicYN="N">osteoarthritis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>10</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37261347</ArticleId><ArticleId IdType="pmc">PMC10227589</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1166536</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang Y, Chen J, Fu H, Kuang S, He F, Zhang M, et al. . Exosomes derived from 3D-cultured MSCs improve therapeutic effects in periodontitis and experimental colitis and restore the Th17 cell/Treg balance in inflamed periodontium. Int J Oral Sci (2021) 13(1):43. doi:&#xa0;10.1038/s41368-021-00150-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41368-021-00150-4</ArticleId><ArticleId IdType="pmc">PMC8671433</ArticleId><ArticleId IdType="pubmed">34907166</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C, McKee C, Bakshi S, Walker K, Hakman E, Halassy S, et al. . Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regener Med (2019) 13(9):1738&#x2013;55. doi:&#xa0;10.1002/term.2914</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.2914</ArticleId><ArticleId IdType="pubmed">31216380</ArticleId></ArticleIdList></Reference><Reference><Citation>Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci (2019) 76(17):3323&#x2013;48. doi:&#xa0;10.1007/s00018-019-03125-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03125-1</ArticleId><ArticleId IdType="pubmed">31055643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci (2014) 15(3):4142&#x2013;57. doi:&#xa0;10.3390/ijms15034142</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15034142</ArticleId><ArticleId IdType="pmc">PMC3975389</ArticleId><ArticleId IdType="pubmed">24608926</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells (2017) 35(4):851&#x2013;8. doi:&#xa0;10.1002/stem.2575</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2575</ArticleId><ArticleId IdType="pubmed">28294454</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics. (2013) 13(10-11):1637&#x2013;53. doi:&#xa0;10.1002/pmic.201200373</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201200373</ArticleId><ArticleId IdType="pubmed">23335344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BC, Kang I, Yu KR. Therapeutic features and updated clinical trials of mesenchymal stem cell (MSC)-derived exosomes. J Clin Med (2021) 10(4):711. doi:&#xa0;10.3390/jcm10040711</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040711</ArticleId><ArticleId IdType="pmc">PMC7916919</ArticleId><ArticleId IdType="pubmed">33670202</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol (2020) 1253:3&#x2013;55. doi:&#xa0;10.1007/978-981-15-3449-2_1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-3449-2_1</ArticleId><ArticleId IdType="pubmed">32445090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Theleman JL, Lygrisse KA, Wang J. Epigenetic mechanisms underlying the aging of articular cartilage and osteoarthritis. Gerontology. (2019) 65(4):387&#x2013;96. doi:&#xa0;10.1159/000496688</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000496688</ArticleId><ArticleId IdType="pmc">PMC9150844</ArticleId><ArticleId IdType="pubmed">30970348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan C. Nonresolving inflammation redux. Immunity. (2022) 55(4):592&#x2013;605. doi:&#xa0;10.1016/j.immuni.2022.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC9003810</ArticleId><ArticleId IdType="pubmed">35417674</ArticleId></ArticleIdList></Reference><Reference><Citation>Surace AEA, Hedrich CM. The role of epigenetics in Autoimmune/Inflammatory disease. Front Immunol (2019) 10:1525. doi:&#xa0;10.3389/fimmu.2019.01525</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01525</ArticleId><ArticleId IdType="pmc">PMC6620790</ArticleId><ArticleId IdType="pubmed">31333659</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, et al. . Epigenetic regulation in fibrosis progress. Pharmacol Res (2021) 173:105910. doi:&#xa0;10.1016/j.phrs.2021.105910</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105910</ArticleId><ArticleId IdType="pubmed">34562602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei A, Gao Q, Chen F, Zhu X, Chen X, Zhang L, et al. . Inhibition of DNA methylation de-represses peroxisome proliferator-activated receptor-&#x3b3; and attenuates pulmonary fibrosis. Br J Pharmacol (2022) 179(7):1304&#x2013;18. doi:&#xa0;10.1111/bph.15655</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15655</ArticleId><ArticleId IdType="pubmed">34378791</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. (2004) 429(6990):457&#x2013;63. doi:&#xa0;10.1038/nature02625</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02625</ArticleId><ArticleId IdType="pubmed">15164071</ArticleId></ArticleIdList></Reference><Reference><Citation>Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep (2011) 63(3):629&#x2013;42. doi:&#xa0;10.1016/s1734-1140(11)70575-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1734-1140(11)70575-8</ArticleId><ArticleId IdType="pubmed">21857074</ArticleId></ArticleIdList></Reference><Reference><Citation>Alizadeh M, Nafari A, Safarzadeh A, Veiskarami S, Almasian M, Asghar Kiani A. The impact of EGCG and RG108 on SOCS1 promoter DNA methylation and expression in U937 leukemia cells. Rep Biochem Mol Biol (2021) 10(3):455&#x2013;61. doi:&#xa0;10.52547/rbmb.10.3.455</Citation><ArticleIdList><ArticleId IdType="doi">10.52547/rbmb.10.3.455</ArticleId><ArticleId IdType="pmc">PMC8718778</ArticleId><ArticleId IdType="pubmed">34981023</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Manero G, Abaza Y, Takahashi K, Medeiros BC, Arellano M, Khaled SK, et al. . Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study. Blood Adv (2019) 3(4):508&#x2013;18. doi:&#xa0;10.1182/bloodadvances.2018027409</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2018027409</ArticleId><ArticleId IdType="pmc">PMC6391673</ArticleId><ArticleId IdType="pubmed">30760466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanaugh SM, White LA, Kolesar JM. Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma. Am J Health Syst Pharm (2010) 67(10):793&#x2013;7. doi:&#xa0;10.2146/ajhp090247</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp090247</ArticleId><ArticleId IdType="pubmed">20479100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jairath V, Khanna R, Feagan BG. Alicaforsen for the treatment of inflammatory bowel disease. Expert OpinInvestig Drugs (2017) 26(8):991&#x2013;7. doi:&#xa0;10.1080/13543784.2017.1349753</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2017.1349753</ArticleId><ArticleId IdType="pubmed">28670932</ArticleId></ArticleIdList></Reference><Reference><Citation>Marafini I, Sedda S, Dinallo V, Monteleone G. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opin Biol Ther (2019) 19(11):1207&#x2013;17. doi:&#xa0;10.1080/14712598.2019.1652267</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2019.1652267</ArticleId><ArticleId IdType="pubmed">31373244</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med (2020) 383(23):2255&#x2013;73. doi:&#xa0;10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, et al. . NLRP3 inflammasome activation triggers gasdermin d-independent inflammation. Sci Immunol (2021) 6(64):eabj3859. doi:&#xa0;10.1126/sciimmunol.abj3859</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abj3859</ArticleId><ArticleId IdType="pmc">PMC8780201</ArticleId><ArticleId IdType="pubmed">34678046</ArticleId></ArticleIdList></Reference><Reference><Citation>Slieker RC, Relton CL, Gaunt TR, Slagboom PE, Heijmans BT. Age-related DNA methylation changes are tissue-specific with ELOVL2 promoter methylation as exception. Epigenet Chromatin. (2018) 11(1):25. doi:&#xa0;10.1186/s13072-018-0191-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-018-0191-3</ArticleId><ArticleId IdType="pmc">PMC5975493</ArticleId><ArticleId IdType="pubmed">29848354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet (2018) 19(2):81&#x2013;92. doi:&#xa0;10.1038/nrg.2017.80</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2017.80</ArticleId><ArticleId IdType="pubmed">29033456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H, Zhao H. Epigenetic factors in atherosclerosis: DNA methylation, folic acid metabolism, and intestinal microbiota. Clin Chim Acta (2021) 512:7&#x2013;11. doi:&#xa0;10.1016/j.cca.2020.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.11.013</ArticleId><ArticleId IdType="pubmed">33232735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma HS, Wang EL, Xu WF, Yamada S, Yoshimoto K, Qian ZR, et al. . Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) and DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) is associated with aggressive behavior and hypermethylation of tumor suppressor genes in human pituitary adenomas. Med Sci Monit (2018) 24:4841&#x2013;50. doi:&#xa0;10.12659/MSM.910608</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.910608</ArticleId><ArticleId IdType="pmc">PMC6069575</ArticleId><ArticleId IdType="pubmed">30002361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang Y, et al. . Overview of histone modification. Adv Exp Med Biol (2021) 1283:1&#x2013;16. doi:&#xa0;10.1007/978-981-15-8104-5_1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-8104-5_1</ArticleId><ArticleId IdType="pubmed">33155134</ArticleId></ArticleIdList></Reference><Reference><Citation>Strepkos D, Markouli M, Klonou A, Papavassiliou AG, Piperi C. Histone methyltransferase SETDB1: a common denominator of tumorigenesis with therapeutic potential. Cancer Res (2021) 81(3):525&#x2013;34. doi:&#xa0;10.1158/0008-5472.CAN-20-2906</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-20-2906</ArticleId><ArticleId IdType="pubmed">33115801</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone modification in NSCLC: molecular mechanisms and therapeutic targets. Int J Mol Sci (2021) 22(21):11701. doi:&#xa0;10.3390/ijms222111701</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111701</ArticleId><ArticleId IdType="pmc">PMC8584007</ArticleId><ArticleId IdType="pubmed">34769131</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw A, Liu C, Ivanovski S, Han P. The relevance of DNA methylation and histone modification in periodontitis: a scoping review. Cells. (2022) 11(20):3211. doi:&#xa0;10.3390/cells11203211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11203211</ArticleId><ArticleId IdType="pmc">PMC9601099</ArticleId><ArticleId IdType="pubmed">36291079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. . Metabolic regulation of gene expression by histone lactylation. Nature. (2019) 574(7779):575&#x2013;80. doi:&#xa0;10.1038/s41586-019-1678-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1678-1</ArticleId><ArticleId IdType="pmc">PMC6818755</ArticleId><ArticleId IdType="pubmed">31645732</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. . Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell (2022) 82(9):1660&#x2013;77. doi:&#xa0;10.1016/j.molcel.2022.02.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.02.033</ArticleId><ArticleId IdType="pubmed">35320754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, et al. . Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res (2022) 131(11):893&#x2013;908. doi:&#xa0;10.1161/CIRCRESAHA.122.320488</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.320488</ArticleId><ArticleId IdType="pubmed">36268709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao LY, Song J, Liu Y, Song CX, Yi C. Mapping the epigenetic modifications of DNA and RNA. Protein Cell (2020) 11(11):792&#x2013;808. doi:&#xa0;10.1007/s13238-020-00733-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00733-7</ArticleId><ArticleId IdType="pmc">PMC7647981</ArticleId><ArticleId IdType="pubmed">32440736</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Huang J, Ocansey DKW, Xia Y, Zhao Z, Xu Z, et al. . The emerging clinical application of m6A RNA modification in inflammatory bowel disease and its associated colorectal cancer. J Inflammation Res (2021) 14:3289&#x2013;306. doi:&#xa0;10.2147/JIR.S320449</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S320449</ArticleId><ArticleId IdType="pmc">PMC8289367</ArticleId><ArticleId IdType="pubmed">34290515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R, Li Q, Feng Z, Cai L, Xu Q. m6A reader YTHDF2 regulates LPS-induced inflammatory response. Int J Mol Sci (2019) 20(6):1323. doi:&#xa0;10.3390/ijms20061323</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061323</ArticleId><ArticleId IdType="pmc">PMC6470741</ArticleId><ArticleId IdType="pubmed">30875984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu G, Ren A, Qiu Y, Zhang Y. Epigenetic regulation of osteogenic differentiation of mesenchymal stem cells. Curr Stem Cell Res Ther (2016) 11(3):235&#x2013;46. doi:&#xa0;10.2174/1574888x10666150528153313</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574888x10666150528153313</ArticleId><ArticleId IdType="pubmed">26018226</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. . Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. (2017) 355(6327):842&#x2013;7. doi:&#xa0;10.1126/science.aag1381</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag1381</ArticleId><ArticleId IdType="pmc">PMC5542057</ArticleId><ArticleId IdType="pubmed">28104796</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Wang X, Jia L, Mondal AK, Diallo A, Hawkins GA, et al. . Inhibiting DNA methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. (2014) 155(12):4925&#x2013;38. doi:&#xa0;10.1210/en.2014-1595</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2014-1595</ArticleId><ArticleId IdType="pmc">PMC4239421</ArticleId><ArticleId IdType="pubmed">25251587</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang LP, Yu XH, Chen JZ, Hu M, Zhang YK, Lin HL, et al. . Histone deacetylase 3: a potential therapeutic target for atherosclerosis. Aging Dis (2022) 13(3):773&#x2013;86. doi:&#xa0;10.14336/AD.2021.1116</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.1116</ArticleId><ArticleId IdType="pmc">PMC9116907</ArticleId><ArticleId IdType="pubmed">35656103</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Shang C, Wang B, Wang G, Jin Z, Yao F, et al. . HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis. Biochem Pharmacol (2021) 192:114716. doi:&#xa0;10.1016/j.bcp.2021.114716</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2021.114716</ArticleId><ArticleId IdType="pubmed">34339713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzacasa B, Amati F, Romeo F, Novelli G, Mehta JL. Epigenetic modification in coronary atherosclerosis: JACC review topic of the week. J Am Coll Cardiol (2019) 74(10):1352&#x2013;65. doi:&#xa0;10.1016/j.jacc.2019.07.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.07.043</ArticleId><ArticleId IdType="pubmed">31488273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Zhang Y, Xie L, Wang K, Wang X. Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein e-deficient mice. Exp Ther Med (2021) 22(2):841. doi:&#xa0;10.3892/etm.2021.10273</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.10273</ArticleId><ArticleId IdType="pmc">PMC8210282</ArticleId><ArticleId IdType="pubmed">34149887</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie K, Yi J, Yang Y, Deng M, Yang Y, Wang T, et al. . A broad m6A modification landscape in inflammatory bowel disease. Front Cell Dev Biol (2022) 9:782636. doi:&#xa0;10.3389/fcell.2021.782636</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.782636</ArticleId><ArticleId IdType="pmc">PMC8809481</ArticleId><ArticleId IdType="pubmed">35127705</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Tan WZ, Sutiman N, Lim C, Lee SS, Leong WF, et al. . An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients. Pharmacogenomics J (2020) 20(3):505&#x2013;15. doi:&#xa0;10.1038/s41397-019-0126-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41397-019-0126-9</ArticleId><ArticleId IdType="pubmed">31813937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalla R, Adams AT, Nowak JK, Bergemalm D, Vatn S, Ventham NT, et al. . Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic and immune-inflammatory influences on the circulating methylome. J Crohns Colitis. (2023) 17(2):170&#x2013;84. doi:&#xa0;10.1093/ecco-jcc/jjac127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjac127</ArticleId><ArticleId IdType="pmc">PMC10024547</ArticleId><ArticleId IdType="pubmed">36029471</ArticleId></ArticleIdList></Reference><Reference><Citation>Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, Leoni F, et al. . Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol (2006) 176(8):5015&#x2013;22. doi:&#xa0;10.4049/jimmunol.176.8.5015</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.8.5015</ArticleId><ArticleId IdType="pubmed">16585598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama M, Ozato Y, Tsuji Y, Arao Y, Otsuka C, Hamano Y, et al. . RNA Modification in inflammatory bowel diseases. Biomedicines. (2022) 10(7):1695. doi:&#xa0;10.3390/biomedicines10071695</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071695</ArticleId><ArticleId IdType="pmc">PMC9313455</ArticleId><ArticleId IdType="pubmed">35885000</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, et al. . Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheumatol (2005) 52(10):3110&#x2013;24. doi:&#xa0;10.1002/art.21300</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21300</ArticleId><ArticleId IdType="pubmed">16200590</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrihew C, Kumar B, Heretis K, Rueger DC, Kuettner KE, Chubinskaya S. Alterations in endogenous osteogenic protein-1 with degeneration of human articular cartilage. J Orthop Res (2003) 21(5):899&#x2013;907. doi:&#xa0;10.1016/S0736-0266(03)00055-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0736-0266(03)00055-X</ArticleId><ArticleId IdType="pubmed">12919879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L, et al. . Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res (2022) 10(1):60. doi:&#xa0;10.1038/s41413-022-00226-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-022-00226-9</ArticleId><ArticleId IdType="pmc">PMC9489702</ArticleId><ArticleId IdType="pubmed">36127328</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel M, Sawalha AH. Epigenetic variability in systemic lupus erythematosus: what we learned from genome-wide DNA methylation studies. Curr Rheumatol Rep (2017) 19(6):32. doi:&#xa0;10.1007/s11926-017-0657-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0657-5</ArticleId><ArticleId IdType="pmc">PMC5819620</ArticleId><ArticleId IdType="pubmed">28470479</ArticleId></ArticleIdList></Reference><Reference><Citation>Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, et al. . Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest. (1993) 92(1):38&#x2013;53. doi:&#xa0;10.1172/JCI116576</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116576</ArticleId><ArticleId IdType="pmc">PMC293525</ArticleId><ArticleId IdType="pubmed">7686923</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Tang Q, Zhao M, Liang G, Wu H, Li D, et al. . The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells. Clin Immunol (2015) 158(1):67&#x2013;76. doi:&#xa0;10.1016/j.clim.2015.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2015.03.005</ArticleId><ArticleId IdType="pubmed">25791245</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gomez A, Li T, de la Calle-Fabregat C, Rodr&#xed;guez-Ubreva J, Ciudad L, Catal&#xe0;-Moll F, et al. . Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease. Nat Commun (2021) 12(1):421. doi:&#xa0;10.1038/s41467-020-20715-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20715-x</ArticleId><ArticleId IdType="pmc">PMC7813865</ArticleId><ArticleId IdType="pubmed">33462210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan ZP, Wang B, Hou DY, You RL, Wang XT, Xie WH, et al. . METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia. FEBS Open Bio. (2021) 11(6):1659&#x2013;72. doi:&#xa0;10.1002/2211-5463.13165</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13165</ArticleId><ArticleId IdType="pmc">PMC8167861</ArticleId><ArticleId IdType="pubmed">33932138</ArticleId></ArticleIdList></Reference><Reference><Citation>Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Abomaray FM, et al. . Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev Rep (2013) 9(5):620&#x2013;41. doi: 10.1007/s12015-013-9455-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-013-9455-2</ArticleId><ArticleId IdType="pubmed">23812784</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Wang LY, Wu J, Xu LF, Sun M. The JAK2 inhibitor AG490 regulates the Treg/Th17 balance and alleviates DSS-induced intestinal damage in IBD rats. Clin Exp Pharmacol Physiol (2020) 47(8):1374&#x2013;81. doi:&#xa0;10.1111/1440-1681.13311</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.13311</ArticleId><ArticleId IdType="pubmed">32215928</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsialis V, Wall S, Liu P, Ordovas-Montanes J, Parmet T, Vukovic M, et al. . Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and crohn's disease. Gastroenterology. (2020) 159(2):591&#x2013;608. doi:&#xa0;10.1053/j.gastro.2020.04.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.074</ArticleId><ArticleId IdType="pmc">PMC8166295</ArticleId><ArticleId IdType="pubmed">32428507</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol (2018) 11(1):1&#x2013;10. doi:&#xa0;10.1007/s12328-017-0813-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12328-017-0813-5</ArticleId><ArticleId IdType="pubmed">29285689</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. (2021) 161(4):1118&#x2013;32. doi:&#xa0;10.1053/j.gastro.2021.07.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.07.042</ArticleId><ArticleId IdType="pmc">PMC8564770</ArticleId><ArticleId IdType="pubmed">34358489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol (2021) 18(1):56&#x2013;66. doi:&#xa0;10.1038/s41575-020-00360-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-020-00360-x</ArticleId><ArticleId IdType="pmc">PMC7542092</ArticleId><ArticleId IdType="pubmed">33033392</ArticleId></ArticleIdList></Reference><Reference><Citation>Windsor JW, Kaplan GG. Evolving epidemiology of IBD. Curr Gastroenterol Rep (2019) 21(8):40. doi:&#xa0;10.1007/s11894-019-0705-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-019-0705-6</ArticleId><ArticleId IdType="pubmed">31338613</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgeon N, Gagn&#xe9; JM, Blais M, Gendron FP, Boudreau F, Asselin C. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis. Am J PhysiolGastrointest Liver Physiol (2014) 306(7):G594&#x2013;605. doi:&#xa0;10.1152/ajpgi.00393.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00393.2013</ArticleId><ArticleId IdType="pubmed">24525021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray G, Longworth MS. Epigenetics, DNA organization, and inflammatory bowel disease. Inflammation Bowel Dis (2019) 25(2):235&#x2013;47. doi:&#xa0;10.1093/ibd/izy330</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izy330</ArticleId><ArticleId IdType="pmc">PMC6327229</ArticleId><ArticleId IdType="pubmed">30407525</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T. Regulation of the intestinal barrier by nutrients: the role of tight junctions. Anim Sci J (2020) 91(1):e13357. doi:&#xa0;10.1111/asj.13357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/asj.13357</ArticleId><ArticleId IdType="pmc">PMC7187240</ArticleId><ArticleId IdType="pubmed">32219956</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauregi-Miguel A. The tight junction and the epithelial barrier in coeliac disease. Int Rev Cell Mol Biol (2021) 358:105&#x2013;32. doi:&#xa0;10.1016/bs.ircmb.2020.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ircmb.2020.09.010</ArticleId><ArticleId IdType="pubmed">33707052</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Yang H, Yu J, Li Z, Xu Q, Ding B, et al. . Crocin induces ROS-mediated papillary thyroid cancer cell apoptosis by modulating the miR-34a-5p/PTPN4 axis in vitro . Toxicol Appl Pharmacol (2022) 437:115892. doi:&#xa0;10.1016/j.taap.2022.115892</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2022.115892</ArticleId><ArticleId IdType="pubmed">35085590</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YJ, Xu QW, Xu CH, Li WM. MSC promotes the secretion of exosomal miR-34a-5p and improve intestinal barrier function through METTL3-mediated pre-miR-34A m6A modification. Mol Neurobiol (2022) 59(8):5222&#x2013;35. doi:&#xa0;10.1007/s12035-022-02833-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02833-3</ArticleId><ArticleId IdType="pubmed">35687301</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Liang Z, Wang F, Zhou C, Zheng X, Hu T, et al. . Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight (2019) 4(24):e131273. doi:&#xa0;10.1172/jci.insight.131273</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.131273</ArticleId><ArticleId IdType="pmc">PMC6975270</ArticleId><ArticleId IdType="pubmed">31689240</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Liang X, Song J, Li C, Liu A, Luo Y, et al. . A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther (2021) 12(1):315. doi:&#xa0;10.1186/s13287-021-02404-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02404-8</ArticleId><ArticleId IdType="pmc">PMC8164818</ArticleId><ArticleId IdType="pubmed">34051868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Joel MDM, Yuan J, Wang J, Cai X, Ocansey DKW, et al. . Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils. Inflammopharmacology. (2020) 28(2):603&#x2013;16. doi:&#xa0;10.1007/s10787-019-00683-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-019-00683-5</ArticleId><ArticleId IdType="pubmed">31938969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Zhang ZY, Yuan JT, Ocansey DKW, Tu Q, Zhang X, et al. . hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis. Stem Cell Res Ther (2021) 12(1):416. doi:&#xa0;10.1186/s13287-021-02492-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02492-6</ArticleId><ArticleId IdType="pmc">PMC8296541</ArticleId><ArticleId IdType="pubmed">34294138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Ding C, Chen H, Zhao J, Chen Z, Chen B, et al. . m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-&#x3ba;B-mediated antiapoptotic pathway. Sci Adv (2022) 8(12):eabl5723. doi:&#xa0;10.1126/sciadv.abl5723</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abl5723</ArticleId><ArticleId IdType="pmc">PMC8956260</ArticleId><ArticleId IdType="pubmed">35333576</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Yu W, Zheng G, Li J, Cen S, Ye G, et al. . TNF-&#x3b1;-mediated m6A modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis. Nat Commun (2021) 12(1):5373. doi:&#xa0;10.1038/s41467-021-25710-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25710-4</ArticleId><ArticleId IdType="pmc">PMC8433149</ArticleId><ArticleId IdType="pubmed">34508078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol (2019), 37(5):3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31621562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. (2019) 393(10182):1745&#x2013;59. doi:&#xa0;10.1016/S0140-6736(19)30417-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30417-9</ArticleId><ArticleId IdType="pubmed">31034380</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson AE. Osteoarthritis year in review 2017: clinical. Osteoarthritis Cartilage. (2018) 26(3):319&#x2013;25. doi: 10.1016/j.joca.2017.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2017.11.014</ArticleId><ArticleId IdType="pmc">PMC5835411</ArticleId><ArticleId IdType="pubmed">29229563</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S, Lee K, Ju JH. Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee. Int J Mol Sci (2021) 22(5):2619. doi:&#xa0;10.3390/ijms22052619</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052619</ArticleId><ArticleId IdType="pmc">PMC7961389</ArticleId><ArticleId IdType="pubmed">33807695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofi&#xf1;o-Vian M, Guill&#xe9;n MI, P&#xe9;rez Del Caz MD, Castej&#xf3;n MA, Alcaraz MJ. Extracellular vesicles from adipose-derived mesenchymal stem cells downregulate senescence features in osteoarthritic osteoblasts. Oxid Med Cell Longev (2017) 2017:7197598. doi:&#xa0;10.1155/2017/7197598</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7197598</ArticleId><ArticleId IdType="pmc">PMC5694590</ArticleId><ArticleId IdType="pubmed">29230269</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Zheng X, Zhang W, Chen M, Wang Z, Hao C, et al. . Mesenchymal stem cells in oriented PLGA/ACECM composite scaffolds enhance structure-specific regeneration of hyaline cartilage in a rabbit model. Stem Cells Int (2018) 2018:6542198. doi: 10.1155/2018/6542198</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6542198</ArticleId><ArticleId IdType="pmc">PMC5870110</ArticleId><ArticleId IdType="pubmed">29666653</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Lin L, Zou R, Wen C, Wang Z, Lin F. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis. Cell Cycle (2018) 17(21-22):2411&#x2013;22. doi:&#xa0;10.1080/15384101.2018.1526603</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2018.1526603</ArticleId><ArticleId IdType="pmc">PMC6342066</ArticleId><ArticleId IdType="pubmed">30324848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Wyckoff J, Morris AT, Succop A, Avery A, Duncan GE, et al. . DNA Methylation associated with healthy aging of elderly twins. Geroscience. (2018) 40(5-6):469&#x2013;84. doi:&#xa0;10.1007/s11357-018-0040-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-018-0040-0</ArticleId><ArticleId IdType="pmc">PMC6294724</ArticleId><ArticleId IdType="pubmed">30136078</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Jia Y, Liu H, He M, Yang Y, Xiao W, et al. . RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets. Am J Transl Res (2019) 11(9):5324&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789288</ArticleId><ArticleId IdType="pubmed">31632513</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T, Chen R, Wu D, Cai N, Shi X, Li B, et al. . Alpha-mangostin suppresses interleukin-1&#x3b2;-induced apoptosis in rat chondrocytes by inhibiting the NF-&#x3ba;B signaling pathway and delays the progression of osteoarthritis in a rat model. Int Immunopharmacol. (2017) 52:156&#x2013;62. doi:&#xa0;10.1016/j.intimp.2017.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.08.021</ArticleId><ArticleId IdType="pubmed">28915439</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu B, Xu X, Yi P, Hao Y. Curcumin reinforces MSC-derived exosomes in attenuating osteoarthritis via modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 signalling pathways. J Cell Mol Med (2020) 24(18):10855&#x2013;65. doi:&#xa0;10.1111/jcmm.15714</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15714</ArticleId><ArticleId IdType="pmc">PMC7521270</ArticleId><ArticleId IdType="pubmed">32776418</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao G, Wu P, Zhang Z, Zhang Z, Liao W, Li Y, et al. . MicroRNA-92a-3p regulates aggrecanase-1 and aggrecanase-2 expression in chondrogenesis and IL-1&#x3b2;-Induced catabolism in human articular chondrocytes. Cell PhysiolBiochem. (2017) 44(1):38&#x2013;52. doi:&#xa0;10.1159/000484579</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484579</ArticleId><ArticleId IdType="pubmed">29241192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao G, Zhang Z, Hu S, Zhang Z, Chang Z, Huang Z, et al. . Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res Ther (2018) 9(1):247. doi:&#xa0;10.1186/s13287-018-1004-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-1004-0</ArticleId><ArticleId IdType="pmc">PMC6158854</ArticleId><ArticleId IdType="pubmed">30257711</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumdar MK, Askew R, Schelling S, Stedman N, Blanchet T, Hopkins B, et al. . Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheumatol (2007) 56(11):3670&#x2013;4. doi:&#xa0;10.1002/art.23027</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23027</ArticleId><ArticleId IdType="pubmed">17968948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao G, Xu Y, Long D, Sun H, Li H, Xin R, et al. . Exosome-transported circRNA_0001236 enhances chondrogenesis and suppress cartilage degradation via the miR-3677-3p/Sox9 axis. Stem Cell Res Ther (2021) 12(1):389. doi:&#xa0;10.1186/s13287-021-02431-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02431-5</ArticleId><ArticleId IdType="pmc">PMC8278601</ArticleId><ArticleId IdType="pubmed">34256841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Kuang L, Chen C, Yang J, Zeng WN, Li T, et al. . miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. (2019) 206:87&#x2013;100. doi:&#xa0;10.1016/j.biomaterials.2019.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2019.03.022</ArticleId><ArticleId IdType="pubmed">30927715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Xu B. TGF-&#x3b2;1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6. Cell Tissue Res (2021) 384(1):113&#x2013;27. doi:&#xa0;10.1007/s00441-020-03319-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-020-03319-1</ArticleId><ArticleId IdType="pubmed">33404840</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Song DY, Huang J, Yang HQ, You D, Ni JD. Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2. Mol Med (2021) 27(1):12. doi:&#xa0;10.1186/s10020-021-00272-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00272-9</ArticleId><ArticleId IdType="pmc">PMC7866678</ArticleId><ArticleId IdType="pubmed">33546582</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Goyal A, Varacallo M. Systemic lupus erythematosus. 2022 sep 4. In: StatPearls. Treasure Island FL: StatPearls Publishing; (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">30571026</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol (2018) 9:2279. doi:&#xa0;10.3389/fimmu.2018.02279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02279</ArticleId><ArticleId IdType="pmc">PMC6180207</ArticleId><ArticleId IdType="pubmed">30337927</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Ugarte-Gil MF, Alarc&#xf3;n GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol (2017) 13(8):799&#x2013;814. doi:&#xa0;10.1080/1744666X.2017.1327352</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2017.1327352</ArticleId><ArticleId IdType="pubmed">28471259</ArticleId></ArticleIdList></Reference><Reference><Citation>Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun (2019) 96:1&#x2013;13. doi:&#xa0;10.1016/j.jaut.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.11.001</ArticleId><ArticleId IdType="pmc">PMC6310637</ArticleId><ArticleId IdType="pubmed">30448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Tello B, Ezeonyeji A, Isenberg D. The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness. Lupus Sci Med (2017) 4(1):e000182. doi:&#xa0;10.1136/lupus-2016-000182</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000182</ArticleId><ArticleId IdType="pmc">PMC5294023</ArticleId><ArticleId IdType="pubmed">28243455</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnas JL, Looney RJ, Anolik JH. B cell targeted therapies in autoimmune disease. CurrOpin Immunol (2019) 61:92&#x2013;9. doi:&#xa0;10.1016/j.coi.2019.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2019.09.004</ArticleId><ArticleId IdType="pmc">PMC6982404</ArticleId><ArticleId IdType="pubmed">31733607</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou R, Zhang X, Xu X, Wang P, Yan B. Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization. Mol Immunol (2021) 139:106&#x2013;14. doi:&#xa0;10.1016/j.molimm.2021.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.08.015</ArticleId><ArticleId IdType="pubmed">34464838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Johnson-Stephenson TK, Wang W, Wang Y, Li J, Li L, et al. . Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17+ regulatory T cell. Stem Cell Res Ther (2022) 13(1):484. doi:&#xa0;10.1186/s13287-022-03174-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-03174-7</ArticleId><ArticleId IdType="pmc">PMC9509559</ArticleId><ArticleId IdType="pubmed">36153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang E, Jeong M, Kim S, Jang K, Kang BK, Lee DY, et al. . Infusion ofHuman bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development. Cell Transplant (2016) 25(1):1&#x2013;15. doi:&#xa0;10.3727/096368915x688173</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368915x688173</ArticleId><ArticleId IdType="pubmed">25975931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Guo YL, Yang JY, Wang W, Xu J. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis]. Beijing Da XueXue Bao Yi Xue Ban. (2018) 50(6):1014&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30562774</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Chang C, Lu Q. The epigenetics of lupus erythematosus. Adv Exp Med Biol (2020) 1253:185&#x2013;207. doi:&#xa0;10.1007/978-981-15-3449-2_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-3449-2_7</ArticleId><ArticleId IdType="pubmed">32445096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich CM. Epigenetics in SLE. CurrRheumatol Rep (2017) 19(9):58. doi:&#xa0;10.1007/s11926-017-0685-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0685-1</ArticleId><ArticleId IdType="pmc">PMC5532407</ArticleId><ArticleId IdType="pubmed">28752494</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, Wang H, Shi X, Ye L, Yan K, Chen Z, et al. . Disease activity-associated alteration of mRNA m5 c methylation in CD4+ T cells of systemic lupus erythematosus. Front Cell Dev Biol (2020) 8:430. doi:&#xa0;10.3389/fcell.2020.00430</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00430</ArticleId><ArticleId IdType="pmc">PMC7291606</ArticleId><ArticleId IdType="pubmed">32582707</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Liu D, Chen C, Hamamura K, Moshaverinia A, Yang R, et al. . MSC transplantation improves osteopenia via epigenetic regulation of notch signaling in lupus. Cell Metab (2015) 22(4):606&#x2013;18. doi:&#xa0;10.1016/j.cmet.2015.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.08.018</ArticleId><ArticleId IdType="pmc">PMC4731233</ArticleId><ArticleId IdType="pubmed">26365178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Zhou Q, Fu T, Zhao R, Yang J, Kong X, et al. . Circulating exosomes derived-miR-146a from systemic lupus erythematosus patients regulates senescence of mesenchymal stem cells. BioMed Res Int (2019) 2019:6071308. doi:&#xa0;10.1155/2019/6071308</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/6071308</ArticleId><ArticleId IdType="pmc">PMC6679864</ArticleId><ArticleId IdType="pubmed">31428639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, et al. . Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis (2022) 13(3):271. doi:&#xa0;10.1038/s41419-022-04708-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04708-w</ArticleId><ArticleId IdType="pmc">PMC8960810</ArticleId><ArticleId IdType="pubmed">35347117</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao M, Xu Q, Wu Z, Chen Y, Shu Y, Cao X, et al. . Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res Ther (2020) 11(1):37. doi:&#xa0;10.1186/s13287-020-1550-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-1550-0</ArticleId><ArticleId IdType="pmc">PMC6979401</ArticleId><ArticleId IdType="pubmed">31973730</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao C, Chen Y, Yang T, Zhao H, Li D. Mesenchymal stem cell derived exosomes suppress neuronal cell ferroptosis Via lncGm36569/miR-5627-5p/FSP1 axis in acute spinal cord injury. Stem Cell Rev Rep (2022) 18(3):1127&#x2013;42. doi:&#xa0;10.1007/s12015-022-10327-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-022-10327-x</ArticleId><ArticleId IdType="pubmed">35257299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Luo Y, Zhang H, Zhang F, Gao X, Shao J. Exosomes derived from mesenchymal stem cells ameliorate the progression of atherosclerosis in ApoE-/- mice via FENDRR. Cardiovasc Toxicol (2022) 22(6):528&#x2013;44. doi:&#xa0;10.1007/s12012-022-09736-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12012-022-09736-8</ArticleId><ArticleId IdType="pubmed">35344140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yan J, Li Z, Zheng J, Sun Q. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate psoriasis-like skin inflammation. J Interferon Cytokine Res (2022) 42(1):8&#x2013;18. doi:&#xa0;10.1089/jir.2021.0146</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2021.0146</ArticleId><ArticleId IdType="pubmed">35041513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao G, Wang L, Li C. Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma. Am J Cancer Res (2022) 12(5):1934&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9185628</ArticleId><ArticleId IdType="pubmed">35693076</ArticleId></ArticleIdList></Reference><Reference><Citation>Noe JT, Rendon BE, Geller AE, Conroy LR, Morrissey SM, Young LEA, et al. . Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci Adv (2021) 7(46):eabi8602. doi:&#xa0;10.1126/sciadv.abi8602</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abi8602</ArticleId><ArticleId IdType="pmc">PMC8589316</ArticleId><ArticleId IdType="pubmed">34767443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocansey DKW, Xu X, Zhang Lu, Mao. F. Mesenchymal stem cell-derived exosome:The likely game-changer in stem cell research. BIOCELL (2022) 46(5):1169&#x2013;72. doi: 10.32604/biocell.2022.018470</Citation><ArticleIdList><ArticleId IdType="doi">10.32604/biocell.2022.018470</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res (2021) 31:61&#x2013;74. doi:&#xa0;10.1016/j.jare.2021.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.01.001</ArticleId><ArticleId IdType="pmc">PMC8240105</ArticleId><ArticleId IdType="pubmed">34194832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>